Let Them Eat Cake
European governments are trying to have it both ways: they're encouraging the creation-by-merger of large national companies at the same time they're trying to create national biotech industries. But biotechs need more companies to do deals with--not fewer. And the larger the companies that the mergers create, the more likely the new megafirms will turn to American biotechs for their deals.
You may also be interested in...
Effective medical device regulation supports both safety and innovation needs. This article assesses how well the US FDA and the Australian TGA achieve this balance.
GSK achieved a first-in-class market oncology launch in 2020, but will have to increase that hit rate in order to fulfil its blockbuster ambitions.